Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $0.70 in the prior trading day, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) closed at $0.71, up 1.33%. In other words, the price has increased by $1.33 from its previous closing price. On the day, 1.99 million shares were traded.
Ratios:
Our goal is to gain a better understanding of IRWD by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1.11. For the most recent quarter (mrq), Quick Ratio is recorded 4.69 and its Current Ratio is at 3.34.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 10 ’25 when MCCOURT Thomas A sold 139,064 shares for $1.76 per share. The transaction valued at 244,753 led to the insider holds 1,160,634 shares of the business.
Silver Ronald sold 12,048 shares of IRWD for $21,204 on Feb 10 ’25. The Principal Accounting Officer now owns 279,655 shares after completing the transaction at $1.76 per share. On Feb 10 ’25, another insider, Shetzline Michael, who serves as the SVP, CMO, Head-Res&Drug of the company, sold 41,269 shares for $1.76 each. As a result, the insider received 72,633 and left with 554,007 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.36.
Stock Price History:
Over the past 52 weeks, IRWD has reached a high of $7.22, while it has fallen to a 52-week low of $0.59. The 50-Day Moving Average of the stock is -40.24%, while the 200-Day Moving Average is calculated to be -78.76%.
Shares Statistics:
A total of 161.81M shares are outstanding, with a floating share count of 156.66M. Insiders hold about 3.18% of the company’s shares, while institutions hold 87.61% stake in the company.
